Intranasal Ketamine for Acute Pain: Behavioral and Neurophysiological Safety Analysis in Mice
ABSTRACT: Background: Subanesthetic ketamine has been used for treatment-resistant depression and is popular as an opioid-sparing agent. Objective: The present study aimed to investigate the dose-dependent antinociceptive effect of intranasal ketamine (INK) along with behavioral and neurophysiologic...
Saved in:
Main Authors: | Nidhi Goswami, M.Sc (Author), Mohd Aleem, M.Sc (Author), Kailash Manda, Ph.D (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analgesic effect of intranasal ketamine in the treatment of chronic cancer pain
by: Secundino González Pardo, et al.
Published: (2022) -
Intranasal dexmedetomidine and intranasal ketamine association allows shorter induction time for pediatric sedation compared to intranasal dexmedetomidine and oral midazolam
by: Francesca Cossovel, et al.
Published: (2022) -
The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review
by: Ludivine Boudieu, et al.
Published: (2023) -
Comparison of intranasal ketamine with intranasal midazolam and dexmedetomidine combination in pediatric dental patients for procedural sedation: A crossover study
by: Bibhav Dubey, et al.
Published: (2024) -
Efficacy and safety of Intranasal Ketamine and Midazolam for sedation of young pediatric patients; a double-blind, randomized clinical trial
by: Hossein Khoshrang, et al.
Published: (2021)